HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Other Non-Current Assets came in at $10.3 million in Q4 2025, up 114.65% year-on-year from $4.8 million in Q4 2024, and down 74.59% on a QoQ basis from $40.6 million in Q2 2025.
HUTCHMED (China) (HCM) Other Non-Current Assets (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Other Non-Current Assets data on file, last reported at $10.3 million in Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 114.65% year-over-year to $10.3 million in Q4 2025; TTM through Dec 2025 was $10.3 million, a 114.65% increase from a year earlier, with the FY2025 full-year figure at $20.1 million, up 61.47% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $10.3 million, down from $40.6 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for HCM reached as high as $4.5 billion in Q4 2023 and fell as low as $4.8 million in Q4 2024.
- Historically, Other Non-Current Assets has averaged $426.6 million across 5 years, with a median of $27.0 million in 2021.
- Across the five-year window, Other Non-Current Assets surged 87351.98% in 2023 and tumbled 99.89% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $5.5 million in 2021, then slipped by 7.39% to $5.1 million in 2022, then jumped by 87351.98% to $4.5 billion in 2023, then tumbled by 99.89% to $4.8 million in 2024, then soared by 114.65% to $10.3 million in 2025.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $10.3 million in Q4 2025, $40.6 million in Q2 2025, and $4.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 10.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.32 Mn |
| Jun 30, 2025 | 40.62 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Jun 30, 2024 | 37.27 Mn |
| Dec 31, 2023 | 4.45 Bn |
| Jun 30, 2023 | 39.55 Mn |
| Dec 31, 2022 | 5.09 Mn |
| Jun 30, 2022 | 45.04 Mn |
| Dec 31, 2021 | 5.50 Mn |
| Jun 30, 2021 | 24.71 Mn |
| Mar 31, 2021 | 26.97 Mn |
| Dec 31, 2020 | 20.17 Mn |
| Jun 30, 2020 | 6.64 Mn |
| Dec 31, 2019 | 253,000.00 |
| Sep 30, 2019 | 6.58 Mn |
| Jun 30, 2019 | 6.77 Mn |
| Mar 31, 2019 | 6.77 Mn |
| Dec 31, 2018 | 292,000.00 |
| Jun 30, 2018 | 6.58 Mn |
| Dec 31, 2017 | 1.65 Mn |